Nova Eye Medical Ltd (EYE.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -298 | -211 | -263 | -134 | -383 |
| Net Acquisitions | N/A | N/A | N/A | 2,015 | -991 |
| Purchase Sale Intangibles | -128 | -238 | -304 | -3,588 | -426 |
| Other Investing Activity | 62 | 124 | -130 | -2,834 | -1,180 |
| Investing Cash Flow | $-364 | $-325 | $-697 | $-4,541 | $-2,980 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,169 | 7,430 | 7,470 | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -41,644 |
| Dividend Paid | N/A | N/A | N/A | N/A | -19,386 |
| Other Financing Activity | -613 | -518 | -653 | -402 | -582 |
| Financing Cash Flow | $5,556 | $6,912 | $6,817 | $-402 | $-61,612 |
| Exchange Rate Effect | -138 | 2 | 123 | -140 | -112 |
| Beginning Cash Position | 6,151 | 7,419 | 8,000 | 17,801 | 95,649 |
| End Cash Position | 5,055 | 6,151 | 7,419 | 8,000 | 17,801 |
| Net Cash Flow | $-958 | $-1,270 | $-704 | $-9,661 | $-77,736 |
| Free Cash Flow | |||||
| Capital Expenditure | -426 | -449 | -800 | -5,591 | -2,228 |
| Free Cash Flow | -426 | -449 | -800 | -5,591 | -2,228 |